Tech Company Financing Transactions
Mitochon Pharmaceuticals Funding Round
Mitochon Pharmaceuticals closed a $425 thousand funding round on 4/29/2016. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/29/2016
Transaction Type
Debt
Amount
$425,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
970 Cross Ln.
Blue Bell, PA 19422
USA
Blue Bell, PA 19422
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our mission is to bring forward meaningful drugs that work at the root of insidious diseases by modulating the mitochondria directly to attenuate disease progression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Alonso
Chief Medical Officer
Marcus Keep
Chief Scientific Officer
John Geisler
Browse more venture capital transactions:
Prev: 4/29/2016: Skulpt venture capital transaction
Next: 4/29/2016: GotIt! venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs